Pharmaceutical

Customized Training & Webinars for Pharmaceutical Companies

Updated on

To help companies navigate the complexities of pharmaceutical regulatory management — ranging from intricate regulations and policies to clinical research, GMP technical requirements, and post-marketing supervision — we have developed a training series for pharmaceutical companies.

Through case studies and interactive sessions led by experienced regulatory professionals, we bridge the gap between knowledge and practice, ensuring that the training delivers impactful results.

Our Training Programs

This series covers key stages in drug research and development, clinical, production, quality, and beyond. It systematically organizes and interprets regulatory requirements, essential knowledge, validation points, and key supervision areas in drug management. BaiPharm has developed a set of relatively mature and complete training courses, which primarily cover the following areas:

  1. Regulatory Affairs Guidance and Optimal Pathways to China Product Registration (NDA, ANDA & MA + MAH)

  2. Post-approval Changes

  3. Drug Master File (DMF) Filing

  4. GMP Compliance and Certification

  5. Market Regulatory Supervision of Drugs

  6. China Pharmacovigilance Guide

  7. Regulatory Affairs Guidance on DRP of Overseas MAH

Customized Course Requests

For course needs not found on the above course list, please feel free to email us at info@baipharm.com with the subject "Supplementary Course", detailing your needs including:

  • Course content

  • Schedule

  • Number of trainees

  • Contact information (name, company, position, contact address, zip code, telephone)

The Expert Team will directly reach out with the relevant information and course details.

Why Choose BaiPharm?

BaiPharm, a specialized subsidiary of REACH24H Consulting Group, is dedicated to pharmaceutical regulatory compliance. With offices in the U.S., EU, Japan, and South Korea, our expert team — including regulatory specialists, GxP auditors, consultants, certified toxicologists, and former inspectors — has supported over 600 pharmaceutical firms from 26 countries.

We have delivered tailored training programs and webinars to a wide range of pharmaceutical industry stakeholders, including professional training platforms, MAHs, CMOs, CDMOs, and CROs, across multiple regulatory and operational domains.

These programs are designed and led by experienced regulatory professionals with strong hands-on backgrounds, integrating regulatory interpretation with real-world industry practice, and covering key areas such as R&D strategy, GMP-compliant manufacturing, and quality system compliance.

Related REACH24H Resources and Services

Explore more BaiPharm pharmaceutical regulatory services:

Not sure where to start? Our regulatory experts are ready to help.
Email: customer@reach24h.com

BaiPharm

Written by

BaiPharm

REACH24H

BaiPharm, a wholly owned subsidiary of REACH24H, provides comprehensive pharmaceutical regulatory consulting and technical services for a broad range of pharmaceutical-related products, including intermediates, APIs, excipients, packaging materials, and finished dosage forms. Our integrated service portfolio includes product registration, pharmacovigilance, Domestic Responsible Person (DRP) services for overseas MAHs, GxP compliance, regulatory intelligence, and toxicological risk assessment.

Newsletter Subscription

Sign up to receive event invitations, expert insights, timely news alerts, and other updates.

SUBSCRIBE

Contact Us

REACH24H USA

+1 703 596 8055

REACH24H EU

+353 1 8899 951

REACH24H UK

+44 782 7193124

REACH24H China

+86 571 87103805

REACH24H Korea

+82 2 62451610

REACH24H Japan

+03 5005 0662

REACH24H Singapore

Events

Everything You Need to Know about Canadian Natural Health Products Regulations
Full Image

We use cookies to ensure that you have the best browsing experience on our website, analyze the relevance between you and our content, and further understand our privacy policy.